Manufacturer
36 recalls in our database name Taro Pharmaceuticals U.S.A., Inc. as the manufacturing or recalling firm.
Of the 36 recalls from Taro Pharmaceuticals U.S.A., Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 4 (11%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Taro Pharmaceuticals is recalling 27,792 tubes of Clobetasol Propionate Cream 0.05% because the product failed content uniformity specifications.
Taro Pharmaceuticals is recalling 16,944 tubes of Fluocinonide Gel USP 0.05% because traces of Dapsone were found in the finished product.
Taro Pharmaceuticals is recalling specific lots of Fluocinonide Cream 0.05% due to cross-contamination with hydrocortisone-17-valerate.
Taro Pharmaceuticals is recalling Nystatin and Triamcinolone Acetonide Cream because it failed content uniformity specifications during 18-month stability testing.
Taro Pharmaceuticals is recalling 17,100 kits of Kamedis Bio-Herbal Dandruff Care System because the active ingredient, zinc pyrithione, was found to be subpotent.
Taro Pharmaceuticals is recalling 62,800 tubes of Topicort cream because the medication contained less active ingredient than labeled.
Taro Pharmaceuticals is recalling 36,684 bottles of Children's Loratadine Syrup because blue plastic was found floating in the liquid.
Taro Pharmaceuticals is recalling 1,966 bottles of Carbamazepine 200 mg tablets because they were sold without an approved NDA/ANDA.
Taro Pharmaceuticals is recalling specific lots of Warfarin Sodium tablets because they failed content uniformity specifications. The affected products were distributed in seven US states.
Taro Pharmaceuticals is recalling 850 bottles of Ciclopirox Shampoo 1% because the product is subpotent. The recall is voluntary and nationwide.
Taro Pharmaceuticals is recalling Fluorouracil Topical Cream 5% because out-of-specification results were found in retain samples.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
TARO Pharmaceuticals
pharmaceutical manufacturer
Source: Wikidata (Q16131515), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.